COVID-19疫情期间延误的原因及其对头颈癌诊断的影响
本研究比较了疫情前队列(2019年6月1日至12月31日,327例)与疫情队列(2020年6月1日至12月31日,311例)头颈癌患者的诊断分期与延误情况。疫情队列患者N2-N3期(41% vs 33%,p=0.03)、T3-T4期(63% vs 50%,p=0.002)及III-IV期(71% vs 58%,p<0.001)比例更高,诊断至治疗路径中多个间期显著延长。疫情队列中146例(47%)经历延误,其中112例与COVID-19相关,80例(71%)为临床医生相关因素。
要点
- 疫情队列较疫情前队列N2-N3期比例更高(41% vs 33%,p=0.03)。
- 疫情队列较疫情前队列T3-T4期比例更高(63% vs 50%,p=0.002)。
- 疫情队列中47%(146例)经历延误,临床医生相关因素占71%。
核心结论
- 疫情队列患者诊断时分期更高,诊断路径中间期更长,COVID-19相关的临床医生因素是最常见的延误原因。
研究设计与样本
- 预先定义两个队列进行回顾分析:疫情前队列(2019年6月1日至12月31日)和疫情队列(2020年6月1日至12月31日)。
- 共纳入638例头颈癌患者,其中疫情前队列327例,疫情队列311例。
- 延误按是否与COVID-19相关以及临床医生、患者或政策相关进行分类。
主要发现
- 疫情队列较疫情前队列N2-N3期比例更高(41% vs 33%,p=0.03)。
- 疫情队列较疫情前队列T3-T4期比例更高(63% vs 50%,p=0.002)。
- 疫情队列较疫情前队列III-IV期比例更高(71% vs 58%,p<0.001)。
- 疫情队列多个诊断至治疗路径间期较疫情前队列显著延长。
- 疫情队列中146例(47%)经历延误,其中112例与COVID-19相关;80例(71%)为临床医生相关,15例(13%)为患者相关,17例(15%)为政策相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The causes for delays during the COVID19 pandemic and their impact on head and neck cancer (HNC) diagnosis and staging are not well described. METHODS: Two cohorts were defined a priori for review and analysis-a Pre-Pandemic cohort (June 1 to December 31, 2019) and a Pandemic cohort (June 1 to December 31, 2020). Delays were categorized as COVID-19 related or not, and as clinician, patient, or policy related. RESULTS: A total of 638 HNC patients were identified including 327 in the Pre-Pandemic Cohort and 311 in the Pandemic Cohort. Patients in the Pandemic cohort had more N2-N3 category (41% vs. 33%, p = 0.03), T3-T4 category (63% vs. 50%, p = 0.002), and stage III-IV (71% vs. 58%, p < 0.001) disease. Several intervals in the diagnosis to treatment pathway were significantly longer in the pandemic cohort as compared to the Pre-Pandemic cohort. Among the pandemic cohort, 146 (47%) experienced a delay, with 112 related to the COVID-19 pandemic; 80 (71%) were clinician related, 15 (13%) were patient related, and 17 (15%) were policy related. CONCLUSIONS: Patients in the Pandemic cohort had higher stage disease at diagnosis and longer intervals along the diagnostic pathway, with COVID-19 related clinician factors being the most common cause of delay.
引用
- Gete M, Huang SH, Ringash J, et al. Causes and impact of delays during the COVID-19 pandemic on head and neck cancer diagnosis. Head Neck. 2024. PMID: 38665037. doi:10.1002/hed.27784
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。